- Theoretically, multiple short MD simulations are better than
one extensive MD simulation. This is mainly because multiple
MD simulations can search different directions of the confor-
mational space. - Cosolvent MD simulations use small molecules to search for
potential binding sites. These molecular probes can help us in
revealing buried binding sites.
References
- Nisius B, Sha F, Gohlke H (2012) Structure-
based computational analysis of protein bind-
ing sites for function and druggability predic-
tion. J Biotechnol 159(3):123–134 - Wells JA, McClendon CL (2007) Reaching for
high-hanging fruit in drug discovery at
protein-protein interfaces. Nature 450
(7172):1001–1009 - Hajduk PJ, Huth JR, Tse C (2005) Predicting
protein druggability. Drug Discov Today 10
(23–24):1675–1682 - Barakat KH, Mane JY, Tuszynski JA (2011)
Virtual screening: an overview on methods
and applications, in handbook of research on
computational and systems biology. In: Liu L,
Wei D, Li Y, Lei H (eds) Handbook of research
on computational and systems biology. IGI
Global, New York, pp 28–60 - Ahmed M, Wang F, Levin A et al (2015) Tar-
geting the Achilles heel of the hepatitis B virus:
a review of current treatments against cova-
lently closed circular DNA. Drug Discov
Today 20(5):548–561 - Barakat K (2014) Computer-aided drug design.
J Pharma Care Health Sys 1(4):1000e113 - Bakan A, Nevins N, Lakdawala AS, Bahar I
(2012) Druggability assessment of allosteric
proteins by dynamics simulations in the pres-
ence of probe molecules. J Chem Theory Com-
put 8(7):2435–2447 - Brown SP, Hajduk PJ (2006) Effects of confor-
mational dynamics on predicted protein drugg-
ability. ChemMedChem 1(1):70–72 - Seco J, Luque FJ, Barril X (2009) Binding site
detection and druggability index from first
principles. J Med Chem 52(8):2363–2371 - Henrich S, Salo-Ahen OM, Huang B, Ripp-
mann FF, Cruciani G, Wade RC (2010)
Computational approaches to identifying and
characterizing protein binding sites for ligand
design. J Mol Recognit 23(2):209–219 - Halgren TA (2009) Identifying and character-
izing binding sites and assessing druggability. J
Chem Inf Model 49(2):377–389 - Barakat KH, Law J, Prunotto A et al (2013)
Detailed computational study of the active site
of the hepatitis C viral RNA polymerase to aid
novel drug design. J Chem Inf Model 53
(11):3031–3043 - Viricel CM, Ahmed M, Barakat K (2015)
Human PD-1 binds differently to its human
ligands: a comprehensive modeling study. J
Mol Graph Model 57C:131–142 - Ahmed M, Barakat K (2015) Baby steps toward
modelling the full human programmed Death-
1 (PD-1) pathway. Receptors Clin Investig 2
(3) - Barakat KH, Huzil JT, Jordan KE,
Evangelinos C, Houghton M, Tuszynski J
(2013) A computational model for overcoming
drug resistance using selective dual-inhibitors
for aurora kinase A and its T217D variant. Mol
Pharm 10(12):4572–4589 - Gajewski MM, Tuszynski J, Barakat K, Huzil
JT, Klobukowski M (2013) Interactions of lau-
limalide, peloruside, and their derivatives with
the isoforms ofβ-tubulin. Can J Chem 91
(7):511–517 - Gentile F, Tuszynski JA, Barakat KH (2016)
New design of nucleotide excision repair
(NER) inhibitors for combination cancer ther-
apy. J Mol Graph Model 65:71–82 - Hu G, Wang K, Groenendyk J (2014) Human
structural proteome-wide characterization of
cyclosporine a targets. Bioinformatics 30
(24):3561–3566 - McClendon CL, Friedland G, Mobley DL,
Amirkhani H, Jacobson MP (2009) Quantify-
ing correlations between allosteric sites in ther-
modynamic ensembles. J Chem Theory
Comput 5(9):2486–2502 - Eyrisch S, Helms V (2007) Transient pockets
on protein surfaces involved in protein-protein
interaction. J Med Chem 50(15):3457–3464 - Oleinikovas V, Saladino G, Cossins BP, Gerva-
sio FL (2016) Understanding cryptic pocket
formation in protein targets by enhanced sam-
pling simulations. J Am Chem Soc 138
(43):14257–14263
Prediction of Druggable Binding Sites 101